Replies to post #319238 on Bioelectronics Corp (BIEL)

[JNdouble1]

This was the obvious speculation several weeks ago when new ActiPatch Retailers in the US started surfacing and pretty much confirmed when the new BIEL Actipatch.com site showed up

Yes it was, and when asked Managment via Investor Relations denied it, in writing.

As stated several times before, the Wave is KT's only FDA Cleared product, without the Wave they are just a 'Wellness Products company', if KT wants to "walk away' from the Wave why did we see retailers selling a new 720 hour Wave in UK/Asia 2 months ago? More likely KT realized that their 250 hour Wave was a mistake and are fixing that error

KT Health LLC was doing fine before hooking up with BIEL, they will do fine without them again. So, you may be right in your opinion of what will happen with KT, I may be. We both seem to be showing our biases. Time will tell.

BIEL is building a new ActiPatch website, that sure does not sound like "decided to focus solely on the RecoveryRx "

Ok, sure they put up a flashy new webpage to sell the one product they have. What resources will they use to drive sales from that site. We all know and hear it here frequently, there is no money for marketing. That was the whole point behind the OEM model. The focus seems to be on clinical trials, meetings with hospitals, insurance reimbursement, and the NoPain act. Continuing to sell a few devices online is a reasonable thing to do, but I haven't still heard a good thesis on how backing away from KT is a good for shareholders.

[GetSeriousOK]

I agree with you that the KT Tape re-writing of their agreement is not a negative. The OEM Partner business model was not the "miracle cure" that Kelly and Keith claimed it would be. Yes, it generated some sales, but the OEM Partners alone won't cut it.

IMO, BIEL needs to sell the ActiPatch OTC if they are ever going to succeed. The KT Tape non-compete clause was a huge mistake.Good to see that they finally remedied that mistake.